Kineta, Inc. is a biotechnology company based in Seattle, WA, specializing in the development of innovative therapeutics for the treatment of various diseases. The organization focuses on harnessing the power of the immune system to create novel solutions, particularly in the fields of oncology and infectious diseases. Kineta's research emphasizes the intersection of immunology and drug development, aiming to address unmet medical needs through cutting-edge scientific advancements.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

15 Patents

#131 in Seattle, WA

#458 in Washington

#21,052 in US

#39,921 in the World

Seattle, WA, United States of America

Kineta, Inc.

Forward Citations = 17

28 inventors:

Shawn P Iadonato (11 out of 29 patents)

Kristin M Bedard (10 out of 10 patents)

Kerry W Fowler (4 out of 45 patents)

4. Matthew Cullen (3 out of 10 patents)

5. Myra Wang Imanaka (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kineta, Inc.. Retrieved from https://idiyas.com/company/kineta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]